TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Double Bond Pharmaceutical AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
128
|
121
|
105 |
| Financial expenses |
10
|
245
|
117 |
| Earnings before taxes |
-945
|
-1,250
|
-1,739 |
| EBITDA |
-918
|
-987
|
-1,606 |
| Total assets |
404
|
432
|
1,133 |
| Current assets |
364
|
376
|
927 |
| Current liabilities |
221
|
287
|
367 |
| Equity capital |
183
|
145
|
766 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
10
|
10
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
45.3%
|
33.6%
|
67.6% |
| Turnover per employee |
13
|
12
|
10 |
| Profit as a percentage of turnover |
-738.3%
|
-1033.1%
|
-1656.2% |
| Return on assets (ROA) |
-231.4%
|
-232.6%
|
-143.2% |
| Current ratio |
164.7%
|
131.0%
|
252.6% |
| Return on equity (ROE) |
-516.4%
|
-862.1%
|
-227.0% |
| Change turnover |
7
|
24
|
62 |
| Change turnover % |
6%
|
25%
|
146% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.